Stelios Tzellos Highlights The Growing Convergence Of Real-World Evidence And Commercial Strategy In Pharma. EINPresswire/ -- Stelios Tzellos, Ph.D., a UK-based pharmaceutical analytics professional ...
Yield loss is increasingly driven by molecular variability in thin films, interfaces, and contamination rather than visible defects. Reliability issues often appear first as parametric drift or margin ...